Myositis – Diagnostics – Overview of Information and Clinical Research

Diagnosing myositis requires a careful combination of tests and examinations, as this rare muscle disease often presents with symptoms that can be difficult to distinguish from other conditions. Because myositis affects people differently and can involve not just muscles but also skin, lungs, and other organs, healthcare providers rely on multiple diagnostic methods to accurately identify the disease and determine the best treatment approach.

Who Should Undergo Diagnostics and When

You should consider seeking medical evaluation if you experience muscle weakness that develops gradually and interferes with your daily activities. This weakness typically affects muscles closest to the center of your body, making it difficult to perform movements you usually can do without thinking. For instance, you might find yourself struggling to stand up from a seated position, having trouble climbing stairs, or experiencing difficulty lifting objects overhead. Some people notice they cannot reach up to comb their hair or hang up a coat, while others find themselves tripping or falling more frequently than usual.^[1]

It is especially important to visit a healthcare provider if you notice muscle weakness accompanied by other symptoms. These might include persistent fatigue that does not improve with rest, joint or muscle pain that lasts longer than a few weeks, or unexplained swelling in your muscles. If you develop a distinctive rash on your eyelids, face, neck, or the backs of your hands, particularly one that is purple-red in color, this could indicate dermatomyositis and warrants immediate medical attention.^[1]

Some warning signs require urgent medical care. You should go to the emergency room if you experience difficulty breathing or trouble swallowing, as these symptoms indicate that myositis may be affecting critical muscles in your throat or diaphragm. These complications can be serious and need immediate evaluation.^[1]

Because myositis is a rare disease, many physicians are unfamiliar with its symptoms, which can make diagnosis challenging. The disease can be difficult to recognize because muscle weakness often develops slowly and subtly over time. Some people may experience symptoms for months before realizing something is wrong. Children and adolescents can also develop myositis, known as juvenile myositis, so parents should be alert to signs of unusual muscle weakness or fatigue in their children.^[2]

Diagnostic Methods Used to Identify Myositis

The diagnosis of myositis typically begins with a thorough physical examination. During this initial assessment, your doctor will evaluate you for muscle weakness and check for any visible rashes on your skin. They will ask detailed questions about your symptoms, including when they started, which activities have become difficult, and whether you have experienced any other health changes. This physical examination helps your provider understand your overall condition and determine which diagnostic tests will be most helpful.^[1]

Blood tests play a crucial role in diagnosing myositis. Your doctor will likely order tests to look for elevated levels of certain enzymes in your blood. One of the most important is creatine kinase, an enzyme that is released when muscle fibers are damaged or inflamed. When creatine kinase levels are significantly higher than normal, this is a strong indicator that muscle inflammation is occurring. Blood tests can also detect specific autoantibodies, which are proteins produced by the immune system that mistakenly attack the body’s own tissues. Different types of myositis are associated with different autoantibodies, so identifying which ones are present can help determine the specific form of the disease.^[5]

A muscle biopsy is considered one of the most reliable tests for diagnosing myositis. During this procedure, a small sample of muscle tissue is removed and examined under a microscope. The biopsy can reveal whether inflammation is present in the muscle fibers, what type of immune cells are involved, and whether there is muscle damage or degeneration. For inclusion body myositis, the biopsy can show characteristic tiny structures called inclusion bodies within the muscle cells. Although a muscle biopsy requires a minor surgical procedure, the information it provides is often essential for confirming the diagnosis and distinguishing myositis from other muscle diseases.^[5]

⚠️ Important

Because myositis is rare and many doctors are not familiar with it, obtaining an accurate diagnosis can take time. If you receive a diagnosis of myositis, consider seeking a second opinion at a myositis specialty center where doctors have extensive experience with the disease. This can ensure you receive the most accurate diagnosis and appropriate treatment plan.

Electromyography, or EMG, is another diagnostic tool that helps evaluate muscle function. This test involves inserting small needles into your muscles to measure their electrical activity. The needles detect how your muscles respond to various electrical nerve signals. In people with myositis, the electrical patterns are typically abnormal, showing signs of muscle inflammation or damage. While the test may sound uncomfortable, it provides valuable information about which muscles are affected and helps differentiate myositis from other conditions that cause muscle weakness.^[5]

Magnetic resonance imaging, commonly known as MRI, offers a non-invasive way to visualize muscles throughout the body. This imaging technique uses magnets and radio waves to create detailed pictures of muscle tissue. An MRI can show areas of inflammation or muscle damage, helping doctors identify which muscle groups are affected by myositis. It can also detect muscle wasting or atrophy. The advantage of MRI is that it does not involve needles or surgery and is completely painless, though you must lie still inside a large machine for the duration of the scan.^[5]

In cases where dermatomyositis is suspected, a skin biopsy may also be performed. This involves removing a small sample of affected skin tissue for examination. The skin biopsy can confirm the presence of inflammation and help distinguish dermatomyositis from other skin conditions that may look similar.^[8]

Additional tests may be needed to check whether myositis has affected other organs. Pulmonary function tests measure how well your lungs are working, which is important because some forms of myositis can cause lung inflammation. An electrocardiogram, or ECG, checks your heart’s electrical activity to detect any cardiac involvement. If you are having trouble swallowing, your doctor may order tests to evaluate the muscles of your esophagus.^[3]

Diagnostics for Clinical Trial Qualification

When patients with myositis are being considered for enrollment in clinical trials, researchers use standardized diagnostic criteria to ensure that all participants have been accurately diagnosed and that the study results will be reliable. These qualification criteria often go beyond what is needed for a standard clinical diagnosis, as clinical trials require very precise and consistent methods for identifying and measuring disease activity.

For clinical trial purposes, the diagnosis of myositis typically must be confirmed through multiple tests. Blood tests showing elevated muscle enzymes, particularly creatine kinase, are standard requirements. Researchers also look for the presence of specific myositis-related autoantibodies, as these can help categorize patients into specific disease subtypes. Many clinical trials focus on particular subtypes of myositis or on patients with certain autoantibody profiles, so identifying these markers is essential for determining eligibility.^[9]

A confirmed muscle biopsy showing characteristic signs of inflammation is frequently required for clinical trial enrollment. The biopsy must demonstrate specific pathological features consistent with myositis, such as the presence of inflammatory cells infiltrating muscle tissue or signs of muscle fiber damage and regeneration. For trials studying dermatomyositis, evidence of the characteristic skin involvement may also be required, which might include a skin biopsy showing typical changes.^[9]

Clinical trials often use standardized assessment tools to measure disease severity and muscle function. Researchers evaluate muscle strength using manual muscle testing, where specific muscle groups are tested and scored according to their strength. Patients may be asked to complete functional assessments that measure their ability to perform daily activities, such as standing from a seated position or climbing stairs. These baseline measurements help researchers determine if patients meet the minimum disease activity requirements for trial participation and provide a starting point for measuring treatment responses.^[9]

Imaging studies, particularly MRI scans of muscles, are increasingly used in clinical trials to objectively document muscle inflammation and damage. These images provide visual evidence of disease activity and can be repeated during the trial to track changes in muscle inflammation over time. Some trials also require pulmonary function tests to document baseline lung function, especially if the trial is testing a treatment for myositis-associated lung disease.^[9]

Patients interested in participating in clinical trials should understand that the diagnostic requirements may be more extensive than what they experienced during their initial diagnosis. Researchers may need to repeat certain tests or perform additional evaluations to confirm eligibility. However, participating in clinical trials can provide access to new treatments that are not yet available to the general public and contributes to advancing medical knowledge about myositis.^[2]

Prognosis and Survival Rate

Prognosis

The prognosis for people with myositis varies significantly depending on several factors, including the specific type of myositis, how quickly treatment begins, and whether the disease affects other organs beyond the muscles. With appropriate treatment, many people with polymyositis and dermatomyositis can achieve remission, a state where disease activity is controlled and symptoms improve. Treatment can put myositis into remission in most cases, though there is currently no cure for the disease.^[1]

The first year after diagnosis is typically the most challenging, as patients and healthcare providers work to find the most effective treatment combination. The disease course can be unpredictable, with periods where symptoms flare up followed by times when they improve. Some people experience mild symptoms that have little impact on their quality of life, while others face more serious manifestations that require intensive medical intervention.^[1]

Dermatomyositis presents unique prognostic considerations. When treatment begins quickly after symptoms appear, patients are more likely to avoid severe complications. However, in rare cases, dermatomyositis can be fatal, particularly in the first year after symptoms begin. This form of myositis also increases the risk of developing certain types of cancer, with cancer found in approximately ten to twenty percent of dermatomyositis cases. Some patients develop cancer before their myositis is diagnosed, while others may develop it afterward.^[1]^[7]

Inclusion body myositis typically has a more gradual but progressive course. Because it is a degenerative muscle disease, muscle weakness tends to worsen slowly over time. Around thirty percent of people with inclusion body myositis develop difficulty swallowing, which can affect nutrition and quality of life. Unfortunately, inclusion body myositis often does not respond as well to immunosuppressive treatments as other forms of myositis.^[1]^[15]

The involvement of organs beyond the muscles significantly impacts prognosis. When myositis affects the lungs, causing interstitial lung disease, this becomes a major factor in disease outcomes. Lung involvement is a leading cause of serious complications in myositis patients. Similarly, if myositis affects the heart or the muscles involved in swallowing, these complications require careful management and can influence long-term outcomes.^[9]

Despite these challenges, many advances have been made in treating myositis. Combining immunosuppressive medications with other therapies, including supervised exercise programs, has improved outcomes for many patients. The development of biologic therapies targeting specific immune system pathways offers new hope for patients who do not respond adequately to conventional treatments. Subgrouping patients based on their specific autoantibody profiles may help identify which treatments will work best for individual patients.^[12]

Survival rate

Specific survival statistics for myositis are difficult to establish with precision because the disease is rare and encompasses several different subtypes, each with varying outcomes. Overall, with modern treatment approaches, the majority of people diagnosed with myositis can expect to live for many years after diagnosis. However, myositis can be a serious illness, and inadequate or absent treatment can lead to significant disability and, in some cases, death.^[2]

The most critical period for survival appears to be the first few years after diagnosis, particularly the first year. During this time, establishing effective disease control is essential. Patients who achieve good control of their disease activity early in their treatment course generally have better long-term outcomes. Those who experience severe organ involvement, particularly of the lungs or heart, face higher risks of serious complications.^[9]

For dermatomyositis specifically, while rare cases can be fatal in the first year, most patients who receive prompt and aggressive treatment can manage their disease over the long term. The association between dermatomyositis and cancer means that regular cancer screening is important for these patients, as early detection of cancer can significantly improve outcomes.^[1]

It is important to recognize that myositis is a chronic disease, meaning it persists over time and requires ongoing management. However, a chronic diagnosis does not mean life cannot be fulfilling. Many people with myositis live exciting and meaningful lives by adapting to their condition, following their treatment plans, staying physically active within their capabilities, and receiving support from healthcare providers, family, and fellow patients.^[19]

#1 Clinical Trials Search in Europe